查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014300

导管固定装置市场：按产品类型、导管类型、应用和最终用户分類的全球市场预测 – 2026-2032 年

Catheter Securement Devices Market by Product Type, Catheter Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，导管固定装置市场价值将达到 12.7 亿美元，到 2026 年将成长到 13.4 亿美元，到 2032 年将达到 20 亿美元，复合年增长率为 6.66%。

主要市场统计数据
基准年 2025 12.7亿美元
预计年份：2026年 13.4亿美元
预测年份 2032 20亿美元
复合年增长率 (%) 6.66%

从策略角度展望导管固定，阐明其临床必要性、操作挑战以及导管固定装置在护理路径中不断变化的作用。

导管固定装置在急诊和门诊护理中发挥着至关重要的作用，它关乎临床安全、手术效率和成本控制。这些装置能够限制导管移位，降低器械相关併发症的发生率，并支持以降低感染风险和提高病患舒适度为优先的照护路径。近年来，临床团队和采购经理逐渐认识到，导管固定装置不仅仅是一种外围附件；它是血管通路策略的重要组成部分，会影响后续的治疗效果，例如导管留置时间、敷料完整性和医护人员工作流程。

材料创新、协议标准化和数位化性能测量如何重新定义所有医疗保健环境中固定设备的选择。

在导管固定领域，一系列变革正在发生，这主要由临床需求和技术进步共同推动。黏合剂的化学改进和一体化敷料系统的创新提高了导管的留置时间和皮肤贴合度，而皮下固定技术的出现则满足了紧急血管通路的需求。同时，由于实证方案的普及和对感染预防日益重视，采购标准也在改变。临床团队现在不仅从单一导管的成本角度评估其固定方案，还会考虑其对整体治疗成本的影响。

贸易政策环境迫使企业重新设计供应链，在地采购，并签订新的采购合同，以维持对先进固定技术的取得。

2025年的关税环境将对资本和耗材密集型产业造成实质压力，导管固定装置也不例外。影响医疗设备组件的关税调整正在更严格地审查依赖跨境供应链采购聚合物、黏合剂和金属组件的製造商的成本。因此，采购团队和原始设备製造商（OEM）正在重新审视筹资策略，以缓解利润率压缩，并在医保报销限制下保持价格竞争力。

细分市场趋势揭示了不同的临床优先事项和采购标准，这取决于产品形式、导管类型、应用和最终用户环境。

了解产品细分有助于明确不同医疗情境下产品采用和临床适用性的驱动因素。根据产品类型，临床医生和采购负责人会考虑将「黏合固定装置」用于常规外周静脉通路，因为这类应用对皮肤友好且易于使用的黏合剂要求较高；而当临床医生寻求能够减少应用步骤和敷料更换次数的整合解决方案时，「整合固定敷料产品」则更受青睐。皮下固定装置适用于活动量大的情况以及需要机械固定的长期中心静脉通路；而当传统固定技术成为标准或成本因素是技术选择的重要考虑因素时，缝合固定装置仍然发挥着重要作用。

区域医疗保健系统和采购惯例正在全球市场中形成不同的部署模式和区域性创新方法。

区域趋势反映了医疗服务模式、管理体制和供应链结构的差异，这些差异影响固定式医疗器材的创新轨迹和应用路径。在美洲，临床上对减少医院感染和增加门诊手术的重视，推动了对整合解决方案和完善的上市后监测的关注；而商业性谈判则通常以基于价值的合约和批量筹资策略为驱动。监管透明度和支付方主导的品质指标，进一步加速了与急诊和门诊医疗机构绩效目标明确一致的医疗器材的应用。

规模和分销网络正在与有针对性的创新、伙伴关係和基于证据的商业化策略竞争。

导管固定领域的竞争动态反映了规模经济与利基市场、专业化创新之间的平衡。成熟的医疗设备製造商利用其广泛的分销网络、丰富的监管经验和整合的产品系列，与医疗系统签订长期合约。这些成熟企业通常专注于提供临床证据、制定标准化培训计划，并确保产品与现有血管通路耗材的兼容性，以最大限度地减少推广阻力。同时，小规模的专业公司则可以透过专注于独特的黏合剂化学、新型固定机製或专有的敷料整合方案，解决特定的临床难题，从而在目标细分市场中确立高端定位。

切实可行的策略措施，旨在帮助製造商和采购商增强韧性、加快部署速度，并在各种医疗保健环境中展现临床价值。

产业领导企业可以采取一系列切实可行的措施，在降低供应和政策波动风险的同时，获得临床和商业性价值。首先，优先进行跨领域研发，汇集临床医生和材料科学家，以加快黏合剂性能和固定人体工学的改进週期。这种方法可以缩短临床应用时间，并提升提案价值。其次，对于关键零件，应采取选择性垂直整合或多源采购策略，以确保供应链的冗余性，并减轻对外贸易中断的影响。

基于实证的混合方法：结合对领域相关人员的访谈、监管和临床文献的整合以及严格的检验，得出可操作的结论。

本分析采用混合方法研究设计，结合与关键相关人员的互动以及对二手证据的严格审查，以确保其可靠性和有效性。主要组成部分包括对急诊、门诊和居家照护机构的临床医生、供应链经理和采购经理进行结构化访谈，以收集有关设备性能、应用流程和采购限制的第一手资讯。二手证据审查涵盖监管指南、临床实践指南和同行评审文献，以支持有关临床性能和应用驱动因素的论点。

整合临床、营运和价值链要求，以确定哪些固定解决方案能够提供可持续的临床和商业性价值。

导管固定装置正从单纯的辅助耗材转变为血管通路管理的关键要素，临床优先事项、供应链现状和技术创新相互交织，共同决定哪些解决方案能够获得持续支持。黏合系统、整合敷料和固定技术的进步旨在解决特定的临床失败模式，但其应用取决于是否与医疗机构的工作流程、采购标准和支付方的期望完全契合。 2025年的贸易和关税环境凸显了弹性采购和协调合约的重要性，显示仅靠卓越的产品已无法保证血管通路的畅通无阻。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 导管固定装置市场：依产品类型划分

  • 黏合固定装置
  • 固定式和敷料一体化产品
  • 皮下固定装置
  • 缝合固定装置

第九章 依导管类型分類的导管固定装置市场

  • 动脉导管
  • 中央静脉导管
  • 透析导管
  • 週边静脉导管

第十章 导管固定装置市场：依应用领域划分

  • 急性导管
  • 慢性导管插入术
  • 血液透析导管

第十一章 导管固定装置市场：依最终使用者划分

  • 门诊手术中心
  • 居家医疗
  • 医院
    • 私立医院
    • 公立医院
  • 专科诊所

第十二章 导管固定装置市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 导管固定装置市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 导管固定装置市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国导管固定装置市场

第十六章：中国导尿管固定装置市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Avanos Medical, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BioDerm, Inc.
  • Centurion Medical Products Corporation
  • Dale Medical Products, Inc.
  • DeRoyal Industries, Inc.
  • ICU Medical, Inc.
  • Medtronic plc
  • Owens & Minor, Inc.
  • Smith & Nephew plc
  • Teleflex Incorporated
  • Terumo Corporation
  • TIDI Products, LLC
  • Vygon SAS
Product Code: MRR-433AB1DC28B9

The Catheter Securement Devices Market was valued at USD 1.27 billion in 2025 and is projected to grow to USD 1.34 billion in 2026, with a CAGR of 6.66%, reaching USD 2.00 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.27 billion
Estimated Year [2026] USD 1.34 billion
Forecast Year [2032] USD 2.00 billion
CAGR (%) 6.66%

A strategic orientation to catheter securement that clarifies clinical imperatives, operational pressures, and the evolving role of securement devices in care pathways

Catheter securement devices occupy a pivotal role at the intersection of clinical safety, procedural efficiency, and cost containment across acute and ambulatory care. These devices mitigate catheter migration, reduce the incidence of device-related complications, and underpin care pathways that prioritize reduced infection risk and improved patient comfort. Over recent years, clinical teams and procurement leaders have increasingly recognized securement as more than a peripheral accessory; it is a component of vascular access strategy that drives downstream outcomes, including dwell time, dressing integrity, and staff workflow.

Consequently, device developers have accelerated product refinements that respond to tighter clinical protocols and heightened scrutiny around hospital-acquired conditions. Concurrently, the rise of outpatient procedures and home-based vascular access has broadened the set of use environments where securement devices must deliver reliable performance under varied handling and hygiene conditions. As regulatory expectations evolve and payors emphasize quality metrics, stakeholders across clinical, supply chain, and product development functions must reassess how securement choices influence overall care pathways. This introduction frames the subsequent analysis by outlining the clinical imperatives, regulatory pressures, and operational realities that collectively shape strategic decisions around catheter securement.

How innovations in materials, protocol standardization, and digital performance measurement are redefining securement device selection across care settings

The catheter securement landscape is experiencing a set of transformative shifts driven by converging clinical priorities and technological advances. Innovations in adhesive chemistry and integrated dressing systems have improved wear time and skin compatibility, while subcutaneous anchoring technologies have emerged to address high-acuity vascular access needs. Simultaneously, the diffusion of evidence-based protocols and heightened emphasis on infection prevention have changed procurement criteria: clinical teams now evaluate securement solutions for total cost of care implications rather than unit cost alone.

Beyond product innovation, digital tools that track catheter dwell-time and device performance are starting to influence adoption decisions, enabling more granular post-market surveillance and clinician feedback loops. Training and competency programs have likewise become more structured, as facilities aim to standardize securement techniques to reduce variability in outcomes. Supply chain considerations have prompted vendors to adopt more resilient sourcing strategies, including regional distribution and component redundancy, to limit disruption. Taken together, these shifts are creating a more integrated ecosystem in which device design, clinical protocols, and data-driven performance measurement jointly determine which securement approaches deliver consistent clinical and economic value.

The trade policy environment has forced supply chain redesigns, localized sourcing, and new procurement agreements to preserve access to advanced securement technologies

The tariff environment in 2025 has exerted tangible pressure on capital and consumable-intensive segments, and catheter securement devices have not been immune to these trade dynamics. Tariff adjustments affecting medical device components have increased cost scrutiny for manufacturers that rely on cross-border supply chains for polymers, adhesives, and metal components. As a direct consequence, procurement teams and original equipment manufacturers have re-evaluated sourcing strategies to mitigate margin compression and preserve competitive pricing for health systems under reimbursement constraints.

In response, many suppliers have pursued a combination of cost-pass-through moderation and operational adjustments, including diversified supplier networks, increased local content, and forward-buy strategies to smooth input price volatility. These measures have realigned inventory policies and altered lead-time planning, prompting hospitals and clinics to build greater visibility into vendor sourcing footprints. Regulatory compliance and customs complexity have also influenced time-to-market for new product introductions, encouraging companies to prioritize product families with fewer cross-border inputs.

Importantly, the tariff backdrop has driven more active dialogue between suppliers and purchasers about total cost implications, not only reported purchase price. As a result, agreements increasingly incorporate longer-term contracting, volume commitments, and collaborative planning to amortize tariff-related cost pressures across the value chain. This evolving commercial architecture offers a pathway to stabilize supply while preserving access to advanced securement technologies despite the headwinds of international trade disruptions.

Segment-specific dynamics reveal differentiated clinical priorities and procurement criteria across product forms, catheter types, applications, and end-user environments

Understanding product segmentation yields clarity on adoption drivers and clinical fit across diverse care scenarios. Based on Product Type, clinicians and procurement officers consider Adhesive Securement Devices for routine peripheral access where skin-friendly adhesives and ease of application matter, while Integrated Securement And Dressing Products gain favor when clinicians seek consolidated solutions that reduce application steps and dressing changes. Subcutaneous Anchoring Devices appeal in high-mobility or long-term central access contexts where mechanical fixation is essential, and Suture Securement Devices remain relevant where traditional fixation techniques are standard or where cost considerations drive technique selection.

Based on Catheter Type, securement requirements differ markedly: Arterial Catheters demand stable fixation for hemodynamic monitoring under frequent manipulation, Central Venous Catheters require solutions that support long-term dwell and complex exit-site management, Dialysis Catheters face heavy-duty performance needs during frequent high-flow exchanges, and Peripheral Intravenous Catheters prioritize rapid, low-disruption placement and frequent dressing access. Based on Application, acute settings emphasize rapid application and infection control for Acute Catheter use, chronic settings prioritize longevity and patient comfort for Chronic Catheter scenarios, and Hemodialysis Catheter applications necessitate durability under sustained use and robust anchoring.

Finally, based on End User, facility-level dynamics shape device selection: Ambulatory Surgical Centers favor streamlined, time-efficient securement that supports high throughput; Home Healthcare contexts require solutions optimized for non-clinical caregivers and variable environments; Hospitals, whether Private Hospitals or Public Hospitals, balance protocols, budgetary controls, and patient acuity when determining acceptable securement modalities; and Specialty Clinics select devices aligned to their procedural volumes and clinician preferences. Synthesizing these segmentation lenses illuminates where product evolution, training, and procurement strategies can most effectively align with clinical needs.

Regional healthcare structures and procurement practices are driving divergent adoption patterns and localized innovation approaches across global markets

Regional dynamics shape both innovation trajectories and adoption pathways for securement devices, reflecting differences in care delivery models, regulatory regimes, and supply chain architecture. In the Americas, clinical emphasis on hospital-acquired infection reduction and outpatient procedure growth has driven interest in integrated solutions and robust post-market surveillance, while commercial negotiations often hinge on value-based contracting and bundled procurement strategies. Regulatory transparency and payer-driven quality metrics further incentivize adoption of devices that demonstrably align with performance objectives in acute and ambulatory settings.

Across Europe, Middle East & Africa, the regulatory mosaic and variance in healthcare infrastructure encourage a bifurcated approach: high-resource centers adopt advanced anchoring and integrated dressing systems, while resource-constrained environments prioritize simple, cost-effective adhesives and durable suture-based methods. Market access pathways here depend on both national reimbursement rules and regional procurement consortia that influence purchasing patterns. In Asia-Pacific, rapid expansion of outpatient services, growing home healthcare segments, and a strong manufacturing base have combined to accelerate both product availability and local innovation. Regional suppliers and contract manufacturers in this geography often play a pivotal role in reducing lead times and cost exposures, and this has prompted international vendors to pursue local partnerships to remain competitive and responsive to regional clinician needs.

A competitive landscape where scale and distribution compete with targeted innovation, partnerships, and evidence-driven commercialization strategies

Competitive dynamics in catheter securement reflect a balance between scale-driven advantages and niche specialist innovation. Established medical device manufacturers leverage broad distribution networks, regulatory experience, and integrated product portfolios to secure long-term contracts with health systems. These incumbents typically emphasize clinical evidence generation, standardized training programs, and compatibility with existing vascular access supplies to minimize adoption friction. Conversely, smaller specialized firms focus on differentiated adhesive chemistries, novel anchoring mechanisms, or unique dressing integrations that address very specific clinical pain points and can command premium positioning in targeted segments.

Across the industry, strategic activity centers on partnerships, targeted licensing agreements, and selective acquisitions that broaden product breadth or accelerate access to proprietary technologies. Manufacturers are also investing in post-market data collection and clinician education to demonstrate comparative performance in real-world settings, thereby strengthening procurement conversations. Supply chain resilience and manufacturing footprint decisions increasingly influence competitive positioning; organizations that can reliably deliver in constrained environments gain preferential consideration from large health systems. Ultimately, the most successful companies align engineering capability, clinical evidence generation, and commercial agility to meet evolving requirements from clinicians and purchasers alike.

Practical strategic moves for manufacturers and purchasers to strengthen resilience, accelerate adoption, and demonstrate clinical value across diverse care environments

Industry leaders can adopt a set of pragmatic actions to capture clinical and commercial value while reducing exposure to supply and policy volatility. First, prioritize cross-functional R&D that pairs clinicians with materials scientists to accelerate iterations on adhesive performance and anchoring ergonomics; this approach reduces time-to-clinical-readiness and strengthens value propositions. Second, pursue selective vertical integration or multi-sourcing strategies for critical components to create redundancy in supply chains and cushion the impact of external trade disruptions.

Third, embed post-market evidence generation into commercialization roadmaps by designing real-world studies that quantify outcomes meaningful to purchasers, such as dressing longevity and device stability; this evidence supports value-based contracting conversations. Fourth, tailor go-to-market models by geography, leveraging local manufacturing partnerships in regions with tariff sensitivity and deploying focused training programs in settings where technique variability drives outcomes. Fifth, engage proactively with regulatory and reimbursement stakeholders to clarify pathways for novel integrations and to expedite adoption in high-impact clinical areas. Finally, invest in clinician education and digital feedback channels to reinforce correct application technique, minimize misuse, and gather continuous performance data that inform iterative product improvements.

An evidence-driven mixed-methods approach combining frontline stakeholder interviews, regulatory and clinical literature synthesis, and rigorous triangulation to support actionable conclusions

This analysis integrates a mixed-methods research design that synthesizes primary stakeholder engagement with rigorous secondary evidence review to ensure robustness and relevance. The primary component included structured interviews with clinicians, supply chain managers, and procurement leaders across acute, ambulatory, and home-care settings to capture experiential insights on device performance, application workflows, and purchasing constraints. The secondary review encompassed regulatory guidance, clinical practice guidelines, and peer-reviewed literature to corroborate clinical performance claims and adoption drivers.

Data triangulation occurred through cross-validation of interview themes against documented clinical outcomes and procurement trends, with attention to regional regulatory distinctions and supply chain configurations. Quality assurance incorporated reviewer adjudication of conflicting perspectives and sensitivity analyses to highlight where evidence is strong versus where open questions remain. The approach prioritized transparency in methodology, reproducibility of key analytical steps, and clarity on limitations, including the evolving nature of product introductions and the variability of local procurement practices. This methodology ensures that conclusions are grounded in current clinical practice and operational realities while acknowledging areas where continued observation will refine understanding.

Synthesis of clinical, operational, and supply chain imperatives that determine which securement solutions will deliver sustained clinical and commercial value

Catheter securement devices have moved from adjunct supplies to strategic elements of vascular access management, and the intersection of clinical priorities, supply chain realities, and technological innovation will determine which solutions gain sustained traction. Advances in adhesive systems, integrated dressings, and anchoring technologies address specific clinical failure modes, but their adoption depends on demonstrable alignment with facility workflows, procurement criteria, and payer expectations. The 2025 trade and tariff environment has amplified the need for resilient sourcing and collaborative contracting, underscoring that product excellence alone no longer guarantees uninterrupted access.

Looking ahead, stakeholders who couple product innovation with robust evidence generation and supply chain flexibility will best position themselves to capture clinical acceptance and procurement preference. Clinical training, digital feedback, and localized manufacturing partnerships will be key enablers. By focusing on total care outcomes and operational reliability, manufacturers and health systems can work together to embed securement choices that reduce complications, streamline care delivery, and support broader quality initiatives. This conclusion synthesizes the report's core insights and highlights avenues for continued strategic action.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Catheter Securement Devices Market, by Product Type

  • 8.1. Adhesive Securement Devices
  • 8.2. Integrated Securement And Dressing Products
  • 8.3. Subcutaneous Anchoring Devices
  • 8.4. Suture Securement Devices

9. Catheter Securement Devices Market, by Catheter Type

  • 9.1. Arterial Catheter
  • 9.2. Central Venous Catheter
  • 9.3. Dialysis Catheter
  • 9.4. Peripheral Intravenous Catheter

10. Catheter Securement Devices Market, by Application

  • 10.1. Acute Catheter
  • 10.2. Chronic Catheter
  • 10.3. Hemodialysis Catheter

11. Catheter Securement Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Home Healthcare
  • 11.3. Hospitals
    • 11.3.1. Private Hospitals
    • 11.3.2. Public Hospitals
  • 11.4. Specialty Clinics

12. Catheter Securement Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Catheter Securement Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Catheter Securement Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Catheter Securement Devices Market

16. China Catheter Securement Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. Avanos Medical, Inc.
  • 17.7. Baxter International Inc.
  • 17.8. Becton, Dickinson and Company
  • 17.9. BioDerm, Inc.
  • 17.10. Centurion Medical Products Corporation
  • 17.11. Dale Medical Products, Inc.
  • 17.12. DeRoyal Industries, Inc.
  • 17.13. ICU Medical, Inc.
  • 17.14. Medtronic plc
  • 17.15. Owens & Minor, Inc.
  • 17.16. Smith & Nephew plc
  • 17.17. Teleflex Incorporated
  • 17.18. Terumo Corporation
  • 17.19. TIDI Products, LLC
  • 17.20. Vygon SAS

LIST OF FIGURES

  • FIGURE 1. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CATHETER SECUREMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CATHETER SECUREMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CATHETER SECUREMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CATHETER SECUREMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY ADHESIVE SECUREMENT DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY ADHESIVE SECUREMENT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY ADHESIVE SECUREMENT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY INTEGRATED SECUREMENT AND DRESSING PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY INTEGRATED SECUREMENT AND DRESSING PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY INTEGRATED SECUREMENT AND DRESSING PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY SUBCUTANEOUS ANCHORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY SUBCUTANEOUS ANCHORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY SUBCUTANEOUS ANCHORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY SUTURE SECUREMENT DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY SUTURE SECUREMENT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY SUTURE SECUREMENT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY ARTERIAL CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY ARTERIAL CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY ARTERIAL CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY CENTRAL VENOUS CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY CENTRAL VENOUS CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY CENTRAL VENOUS CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY DIALYSIS CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY DIALYSIS CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY DIALYSIS CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY ACUTE CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY ACUTE CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY ACUTE CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY CHRONIC CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY CHRONIC CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY CHRONIC CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY HEMODIALYSIS CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY HEMODIALYSIS CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY HEMODIALYSIS CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS CATHETER SECUREMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 114. GCC CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. GCC CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. GCC CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. GCC CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GCC CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. G7 CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. G7 CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. G7 CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. NATO CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. NATO CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NATO CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. NATO CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NATO CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CATHETER SECUREMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES CATHETER SECUREMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA CATHETER SECUREMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA CATHETER SECUREMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA CATHETER SECUREMENT DEVICES MARKET SIZE, BY CATHETER TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA CATHETER SECUREMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA CATHETER SECUREMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA CATHETER SECUREMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)